TargImmune Therapeutics AG is a private Swiss biotechnology company based in Stücki Park in Basel, which was founded in 2016. TargImmune has set itself the goal of significantly improving the survival chances of cancer patients by developing novel targeted cancer therapeutics.

https://targimmune.com/

Map